Thalassemia is a genetic disease and the disease is transmitted from the parents to the babe . The disease is inherit in autosomal recessive pattern . The disease is cause due to sport in genes controlling synthetic thinking of haemoglobin .
Thalassemia is a genetical disorderliness which is inherit from the patient . If both the parents are the carrier , the chances of occurrence of the normal baby are 25 % . Thus , the chances of transfer of the mutate gene in the baby are 75 % in which 50 % probability is of Carrier and 25 % luck is of the pathologic baby . Hemoglobin is composed of heme , alpha hematohiston and beta globin . The synthesis of alpha and genus Beta globin is controlled by the facial expression of genes .
The factor controlling the saying of synthesis of alpha globin are HBA1 and HBA2 and are present on chromosome 16 . The genes controlling the expression of synthetic thinking of genus Beta haematohiston is HBB and is present on chromosome 11 . One pair of HBA1 and one pair of HBA2 is present while the HBB exists in single couplet . This indicates that the deductive reasoning of alpha globin is controlled by four gene while the synthesis of beta hematohiston is controlled by 2 genes .
When the mutation takes piazza in genes of alpha globin , the disease is called alpha thalassemia while the mutation in genes of beta globin results in beta Mediterranean anaemia . The rigour of the disease look upon the number of factor that gets mutated . Thalassemia is inherit in autosomal recessive pattern . It implies that mutation in both the allele is required to certify the symptoms of the disease .
In small percentage of patient , the cistron of beta thalassemia may also show autosomal prevalent pattern which intend mutation in a exclusive allele is sufficient to manifest the symptoms of the disease .
Thalassemia Treatment
Blood blood transfusion : Thalassemia is the condition in which the unnatural Hb is synthesise due to the mutation in the factor responsible for the synthesis of alpha globin and beta globin , the important component of hemoglobin . This incorrect haemoglobin also causes the reduction in red roue cells as off-white marrow is unable to synthesise adequate red rakehell cells with the faulty hemoglobin . This results in mild , temperate or severe anemia . To manage the symptom , frequent blood transfusion is required , and the absolute frequency depends upon the severity of the disease .
Iron Chelation Therapy : Due to frequent parentage transfusion , the iron load of the body increases leading to iron toxicity . The excess iron get-go accumulate the vital electronic organ such as liver and kernel . This precondition becomes more sever due to increased stomachal iron soaking up and reduce formation of carmine blood cells . Iron chelation therapy is recommended in such patients and due to incorporation of branding iron therapy in the thalassemia patient ’s intervention regime , the mortality is significantly foreshorten .
Gene Therapy : factor therapy is another thalassemia treatment approach in which the faulty factor are replace by the correct genes . The transfer of cistron is done through various processes . The most effective process is transfer of genes through oncoretroviral or lentiviral vector . The other techniques involve lap joint - switching and stop codon readthrough .
Stem Cell Transplant : Stem cell organ transplant is transplanting the root cell from a levelheaded conferrer to thalassemia person . Stem cells give rise to various cell such as red blood cells , bloodless bloodline cells and platelet . Stems cells , when taken from bone bone marrow for transplantation , is termed as os marrow transplantation .
Surgery : Surgery is done in the patients who have bone contortion due to Mediterranean anaemia .
Thalassemia is autosomal recessive condition but in some font of beta thalassemia , the condition is inherited in autosomal dominant manner . The gene master the synthesis of alpha and beta globin gets mutate lead in unnatural Hb synthetic thinking .
Also learn :
